| Development of diabetes-specific quality of life module to be in conjunction with the World Health Organization quality of life scale brief version (WHOQOL-BREF) CY Lin, TY Lee, ZJ Sun, YC Yang, JS Wu, HT Ou Health and quality of life outcomes 15, 1-10, 2017 | 49 | 2017 |
| Incidence of diabetes-related complications in Chinese patients with type 1 diabetes: a population-based longitudinal cohort study in Taiwan HT Ou, TY Lee, CY Li, JS Wu, ZJ Sun BMJ open 7 (6), e015117, 2017 | 29 | 2017 |
| Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species HT Ou, TY Lee, YC Chen, C Charbonneau BMC infectious diseases 17, 1-9, 2017 | 27 | 2017 |
| Cost‐effectiveness of long‐acting insulin analogues vs intermediate/long‐acting human insulin for type 1 diabetes: A population‐based cohort followed over 10 years TY Lee, S Kuo, CY Yang, HT Ou British journal of clinical pharmacology 86 (5), 852-860, 2020 | 25 | 2020 |
| Comparative risks of diabetes‐related complications of basal insulins: a longitudinal population‐based cohort of type 1 diabetes 1999–2013 in Taiwan HT Ou, TY Lee, YF Du, CY Li British Journal of Clinical Pharmacology 84 (2), 379-391, 2018 | 6 | 2018 |
| Cost-utility analysis of inotuzumab ozogamicin for relapsed or refractory B cell acute lymphoblastic leukemia from the perspective of Taiwan’s health care system TY Lee, HY Chen, TY Chen, SS Li, WT Fang, YC Wen, YW Lo, HT Ou The European Journal of Health Economics 21, 1105-1116, 2020 | 3 | 2020 |
| Economic burden of interstitial lung disease in a commercially insured population with Sjögren syndrome in the United States TY Lee, JF Slejko, BB Davies-Teye, E Onukwugha Journal of Managed Care & Specialty Pharmacy 28 (7), 786-794, 2022 | 2 | 2022 |
| External validation of lung function predictions in real-world cohorts of COPD Z Zafari, TY Lee, M Sadatsafavi Respiratory Medicine 198, 106859, 2022 | 1 | 2022 |
| Impact of Proactive Adherence Interventions on HIV RNA using Prescription Claims NS Pandit, A Johnson, TY Lee, E Onukwugha, H Cassidy-Stewart | | 2024 |
| Disparity in treatment patterns among Medicare beneficiaries diagnosed with chronic lymphocytic leukemia: an analysis of patient and contextual factors JA Yared, TY Lee, CE Cooke, A Johnson, A Summers, K Yang, S Liu, ... Leukemia & Lymphoma, 1-11, 2024 | | 2024 |
| BUILDING CAPACITY FOR RESEARCH ON CANCER AND AGING: THE UMGCCC-MEDICARE DATABASE TY Lee, E Onukwugha, ES Nahm, J Abree, CC Tung, J Wimbush, ... | | 2023 |
| EE195 Economic Burden of Cardiovascular Disease Among Commercially Insured Adults Diagnosed With Colorectal Cancer in the United States BB Davies-Teye, JF Slejko, TY Lee, E Onukwugha Value in Health 25 (12), S91, 2022 | | 2022 |
| Patient Involvement in Clinical-Practice Guideline Development: Ten Recommended Good Practices TY Lee, B Desai, EM Perfetto | | 2022 |
| Factors Associated with Treatment Among Older Adults Diagnosed with Chronic Lymphocytic Leukemia: An Analysis Using Medicare Claims Data E Onukwugha, TY Lee, J Abree, C Cooke, S Amanda, K Yang, S Liu, ... Blood 138, 1968, 2021 | | 2021 |
| Comparative Risks of Diabetes-Related Complications of Long versus Intermediate Acting Insulin in Type 1 Diabetes TY Lee, HT Ou, YF Du, CY Li PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 26, 2017 | | 2017 |
